Olive, formerly known as CrossChx, is a healthcare-specific artificial intelligence and process automation company that empowers healthcare organizations to improve efficiency and patient care while reducing costly administrative errors.
Olive's mission to build meaningful artificial intelligence that empowers and scales humans to achieve more than ever before.
Olive was founded in 2012 by Brad Mascho & Sean Lane. The company was formerly known as CrossChx and changed it's name to Olive in Sep 2018. Olive is based in Colombus, Ohio.
Olive provides AI solutions to healthcare organizations across the U.S., including hospitals, laboratories and the nation’s leading healthcare management systems. Olive acts as a digital workforce by automating repetitive, high volume tasks and workflows.
Olive is more than just a basic Robotic Process Automation solution. Her advanced Computer Vision and Machine Learning skills, along with fundamental RPA capabilities, enable her to take an impact-driven approach to AI implementation, providing both immediate and long-term value to your healthcare organization.
Olive uses her healthcare-specific skills to address common bottlenecks when it comes to time-consuming, error-prone workflows – from claim status checks and account updates to prior authorizations and more.
Olive has created AI-as-a-service (AIaaS) because we think the current purchasing model for AI is broken. Olive is the only healthcare-specific artificial intelligence solution sold as a service – that means one simple price and an all-in-one approach to optimized healthcare workflows and improved revenue.
Olive gives power back to providers through her ever-growing, unparalleled intelligence made up of shared memories, collective wisdom, and global awareness, learning like a network, so hospitals never have to solve the same problem twice. Its AI workforce has been adopted by over 600 hospitals, including 22% of the top 100 health systems in the country.
Olive is backed by Khosla Ventures, Silicon Valley Bank, General Catalyst, Tiger Global, Oak HC/FT, Ascension Ventures, Drive Capital, SVB Capital and others. The company raised a new $225.5M in Series G round on Dec 01, 2020. This brings Olive's total funding to $455.3M to date. The latest round values the company at $1.5B post-money.